《兒童咳嗽變異性哮喘中藥臨床試驗(yàn)設(shè)計(jì)與評(píng)價(jià)技術(shù)指南》為中華中醫(yī)藥學(xué)會(huì)標(biāo)準(zhǔn)化項(xiàng)目《兒科系列常見病中藥臨床試驗(yàn)設(shè)計(jì)與評(píng)價(jià)技術(shù)指南》之一。其目的是以臨床價(jià)值為導(dǎo)向，在病證結(jié)合模式下，討論具有咳嗽變異性哮喘、兒童和中藥特點(diǎn)的臨床定位、試驗(yàn)設(shè)計(jì)與實(shí)施等相關(guān)問題，為中藥治療兒童咳嗽變異性哮喘臨床試驗(yàn)設(shè)計(jì)與評(píng)價(jià)提供思路和方法。制定過程中先后成立指南工作組、起草專家組和定稿專家組，采用文獻(xiàn)研究和共識(shí)會(huì)議的方法，最終形成指南送審稿定稿。該《指南》的主要內(nèi)容包括臨床定位、試驗(yàn)總體設(shè)計(jì)、診斷標(biāo)準(zhǔn)與辨證標(biāo)準(zhǔn)、受試者的選擇與退出、干預(yù)措施、有效性評(píng)價(jià)、安全性觀察、試驗(yàn)流程、試驗(yàn)的質(zhì)量控制9部分。希望其制定和發(fā)布，能為申辦者/合同研究組織、研究者在中藥治療咳嗽變異性哮喘的臨床試驗(yàn)設(shè)計(jì)，提供借鑒與參考。

Guideline on Design And Evaluation of Clinical Trials for Chinese Medicine in Common Pediatric Diseases: Cough Variant Asthma (Guideline) is one of the standardization projects of the China Association of Traditional Chinese Medicine — Guideline on the Design And Evaluation of Clinical Trials for Chinese Medicine in Common Pediatric Diseases. The purpose is to discuss the clinical positioning, experimental design and implementation of the characteristics of cough variant asthma, children and traditional Chinese medicine under the mode of combining disease and syndrome with clinical value, so as to provide suggestions and methods for the design and evaluation of clinical trial of cough variant asthma with traditional Chinese medicine. In the process of developing, working group on the guidelines, drafter group and a finalizer group were established, and the methods of literature research and consensus meeting were adopted to form the final draft of the guidelines. The main contents of the Guideline include clinical positioning, overall design of the trial, diagnostic and syndrome differentiation criteria, selection and withdrawal of subjects, intervention, effectiveness evaluation, safety observation, trial process, quality control of the trial. The formulation of the Guideline provides references for the sponsor or contract research organizations and researchers to design clinical trials on the treatment of childhood cough variant asthma with traditional Chinese medicine.

R287.5

重大新藥創(chuàng)制項(xiàng)目“兒童中藥新藥臨床評(píng)價(jià)技術(shù)示范性平臺(tái)建設(shè)”（2020ZX09201-008）